OTTAVA launches as a differentiated, table-integrated robotic surgery platform with FDA approval, targeting global expansion and aiming to transform OR efficiency and workflow. Early clinical data show high satisfaction and procedural success, with ongoing innovation and market growth expected.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.